Literature DB >> 11019862

Histochemical and immunohistochemical differential diagnosis of amyloidosis--a brief illustrated essay and personal experience with Romhányi's method.

M Bély1, A Apáthy.   

Abstract

The histochemical and immunohistochemical differential diagnosis of amyloidosis in surgical pathology in a referral center is presented. Different forms of amyloidosis are considered e.g. systemic generalized amyloidosis: secondary (AA), primary (AL), senile, hemodialysis-associated, hereditary and organ (tissue)-limited (localized) amyloidosis: cerebral, dystrophic (age-related, so-called "senile"), endocrine-related, localized to tumours, focal (concentrated secretion), and isolated plasma cell (solitary plasmacytoma, B-cell) dyscrasia related amyloidosis. The amyloid deposits were identified and characterized histochemically by Congo red staining after performate pre-treatment at 20 degrees C for 1, 3, 5, 10, 15, 20 or 25 sec, and with oxidation induced proteolysis by trypsin digestion at 20 degrees C for 5, 10, or 30 sec, 1, 2, 3, 4, 5, 6 or 10 min and covered with gum-arabic according to Romhányi, and confirmed by streptavidin-biotin-complex/horseradish peroxidase immunohistochemical reactions. The "sensitivity" or "resistance" to pre-treatment of amyloid deposits depends on the type of amyloid, and the length of pre-treatment. Secondary (AA) amyloid is sensitive to KMnO4 oxidation, followed by trypsin digestion (for 1 min), and its green birefringence under polarized light disappears, while primary (AL) (for 1-5 min), senile (for 1-10 min), and most forms of organ (tissue)-limited (localized) amyloid (for 1-10 min) are resistant. Performate pre-treatment is followed by pronounced congophilia. Secondary (AA) is sensitive to performate pre-treatment (for 1 sec), while primary (AL) amyloid (for 1-20 sec), senile (for 1-25 sec), and most forms of organ (tissue)-limited (localized, isolated) amyloid deposits (for 1-25 sec) are resistant, and are constantly positively birefringent. Early identification and differentiation of amyloid deposits is important for the prognosis and for the choice of therapy. The authors conclude that the presented classical histochemical methods are useful as first line screens for the histological identification of amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11019862     DOI: 10.3109/13506120009146836

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  5 in total

1.  Incomplete ileus and hemafecia as the presenting features of multi-organ involved primary systemic AL amyloidosis: a rare case report.

Authors:  Li Tian; Anliu Tang; Xian Zhang; Zhen Mei; Fen Liu; Jingbo Li; Xiayu Li; Feiyan Ai; Xiaoyan Wang; Shourong Shen
Journal:  BMC Gastroenterol       Date:  2017-06-05       Impact factor: 3.067

2.  Alkaptonuria is a novel human secondary amyloidogenic disease.

Authors:  Lia Millucci; Adriano Spreafico; Laura Tinti; Daniela Braconi; Lorenzo Ghezzi; Eugenio Paccagnini; Giulia Bernardini; Loredana Amato; Marcella Laschi; Enrico Selvi; Mauro Galeazzi; Alessandro Mannoni; Maurizio Benucci; Pietro Lupetti; Federico Chellini; Maurizio Orlandini; Annalisa Santucci
Journal:  Biochim Biophys Acta       Date:  2012-07-28

3.  Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria.

Authors:  Adriano Spreafico; Lia Millucci; Lorenzo Ghezzi; Michela Geminiani; Daniela Braconi; Loredana Amato; Federico Chellini; Bruno Frediani; Elena Moretti; Giulia Collodel; Giulia Bernardini; Annalisa Santucci
Journal:  Rheumatology (Oxford)       Date:  2013-05-23       Impact factor: 7.580

4.  Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient.

Authors:  Lia Millucci; Lorenzo Ghezzi; Eugenio Paccagnini; Giovanna Giorgetti; Cecilia Viti; Daniela Braconi; Marcella Laschi; Michela Geminiani; Patrizia Soldani; Pietro Lupetti; Maurizio Orlandini; Chiara Benvenuti; Federico Perfetto; Adriano Spreafico; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2014-04-28       Impact factor: 4.711

5.  Autonomic dysfunction in cardiac amyloidosis assessed by heart rate variability and heart rate turbulence.

Authors:  Shinya Yamada; Akiomi Yoshihisa; Naoko Hijioka; Masashi Kamioka; Takashi Kaneshiro; Tetsuro Yokokawa; Tomofumi Misaka; Takafumi Ishida; Yasuchika Takeishi
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-02-21       Impact factor: 1.468

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.